Market Research Logo

Ferring International Center SA - Strategic SWOT Analysis Review

Ferring International Center SA - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (follitropin delta), for controlled ovarian stimulation; Menopur (HP-hMG) for female and male infertility; Firmagon (degarelix) for prostate cancer; and Pentasa (mesalazine) for inflammatory bowel diseases. Its pipeline products encompass FE 999310 for infertility; FE 202767 for Lactation; Testavan for male hypogonadism; and Prefix for lumbar spine fusion, among others. Ferring conducts research and development on biotechnology derived medicines such as recombinant proteins and other biologics. It has production facilities in Argentina, Denmark, Germany, China, the Czech Republic, India, Scotland, Switzerland, Israel, Mexico, and a manufacturing site in the US. Ferring is headquartered at Saint-Prex, Switzerland.

Ferring International Center SA Key Recent Developments

Nov 29,2017: FDA Approves Ferring's CLENPIQ (Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid) Oral Solution for Colonoscopy Prep
Oct 02,2017: Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer
Jul 03,2017: Ferring Appoints Lars Peter Brunse to Executive Board
May 23,2017: Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth
Apr 03,2017: Ferring appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Ferring International Center SA - Key Facts
Ferring International Center SA - Key Employees
Ferring International Center SA - Key Employee Biographies
Ferring International Center SA - Major Products and Services
Ferring International Center SA - History
Ferring International Center SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ferring International Center SA - Business Description
Ferring International Center SA - SWOT Analysis
SWOT Analysis - Overview
Ferring International Center SA - Strengths
Ferring International Center SA - Weaknesses
Ferring International Center SA - Opportunities
Ferring International Center SA - Threats
Ferring International Center SA - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Ferring International Center SA, Recent Deals Summary
Section 4 – Company’s Recent Developments
Nov 29, 2017: FDA Approves Ferring's CLENPIQ (Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid) Oral Solution for Colonoscopy Prep
Oct 02, 2017: Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer
Jul 03, 2017: Ferring Appoints Lars Peter Brunse to Executive Board
May 23, 2017: Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth
Apr 03, 2017: Ferring appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Ferring International Center SA, Key Facts
Ferring International Center SA, Key Employees
Ferring International Center SA, Key Employee Biographies
Ferring International Center SA, Major Products and Services
Ferring International Center SA, History
Ferring International Center SA, Other Locations
Ferring International Center SA, Subsidiaries
Ferring International Center SA, Key Competitors
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Ferring International Center SA, Recent Deals Summary
List of Figures
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report